Table 1.
Demographic characteristics of patients.
| Characteristics | Values (n = 46) |
|---|---|
| Gender | |
| Male, % | 39 (84.78%) |
| Female, % | 7 (15.22%) |
| Age (year) | 46 (18–94) |
| Weight (kg) | 70 (45–98) |
| Creatinine clearance (mlċmin−1) | 89.3 (15.6–315.2) |
| Serum creatinine (µmolċL−1) | 73.0 (21.0–387.0) |
| Urea nitrogen (mmolċL−1) | 9.8 (2.4–59.3) |
| Uric acid (µmolċL−1) | 170.5 (19.0–600.0) |
| Alanine aminotransferase (UċL-1) | 31.0 (3.0–336.0) |
| Aspartate aminotransferase (UċL−1) | 40.0 (12.0–206.0) |
| Glutamyl transpeptidase (UċL−1) | 59.5 (2.0–663.0) |
| Alkaline phosphatase (UċL−1) | 122.0 (44.0–334.0) |
| Total protein (gċL−1) | 57.2 (42.7–75.3) |
| Serum albumin (gċL−1) | 31.5 (18.3–43.6) |
| Total bilirubin (µmolċL−1) | 16.1 (3.6–286.4) |
| Direct bilirubin (µmolċL−1) | 9.4 (1.6–228.9) |
| Daily dose/body weight (mg·kg−1) | 1.91 (1.18–3.33) |
| Daily dose | |
| 100 mg, % | 25 (50.0%) |
| 150 mg, % | 15 (32.6%) |
| 200 mg, % | 8 (17.4%) |
| Injection duration | |
| 0.5 h, % | 2 (4.35%) |
| 1 h, % | 37 (80.43%) |
| 2 h, % | 7 (15.22%) |
| Pathogenic bacteria cultures | |
| Acinetobacter baumannii | 19 |
| Klebsiella pneumoniae | 20 |
| Pseudomonas aeruginosa | 7 |
| Escherichia coli | 4 |
| Others | 2 |
Values are median (range) or No. (%).